Wet AMD 3 Symposium

Related

• 

  Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study

  Priyatham (Prithu) S Mettu, MD

  Updates from the Field

  2019

• 

  Episode 1: Review of the Clarity Study with Dr. Amin Kherani

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2017

• 

  Clinical Utility of the Fellow Eye in Patients With Bilateral GA Due to AMD: Long-Term Data from the Pegcetacoplan Clinical Program

  Diana V Do, MD, FASRS

  Updates from the Field

  2025